Tovorafenib

About

Therapy type: Targeted therapy

Therapy strategy: B-RAF inhibition

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
FDA (1) BRAF rearrangements Low-Grade Glioma, NOS Tovorafenib
FDA (1) v::BRAF Low-Grade Glioma, NOS Tovorafenib
FDA (1) BRAF p.V600E Low-Grade Glioma, NOS Tovorafenib
FDA (1) BRAF p.V600K Low-Grade Glioma, NOS Tovorafenib